“The recall system is broke and needs fixing,” reports the California State Board of Pharmacy’s Enforcement Committee. In October the board began discussing opportunities for recall procedure improvements with hospital pharmacists. In late spring, the board found 94 hospital pharmacies in California that still stocked recalled heparin.
But will pharmacists alone have the answers? Probably not. The board itself told an audience at the 4th Global Forum on Pharmaceutical Anticounterfeiting in June that had California’s electronic pedigree rules been in effect, “wholesalers could have been specific in such recalls.”
With the e-pedigree law delayed until 2015, will recalled products continue to risk patient health? It seems possible. There might not be a direct cause-and-effect link, but item tracking seems awfully difficult without item-level identifiers.